ArticleAnnals of translational medicine2022

Trastuzumab plus pertuzumab in combination with chemotherapy in metastatic HER2-positive breast cancer: a retrospective single-armed cohort study in China.

Yu Qian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.